The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase
- PMID: 10986119
- DOI: 10.1006/jmbi.2000.4090
The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase
Abstract
A total of 38 bicyclomycin-resistant mutants of Escherichia coli transcription termination protein Rho have been isolated. The locations of their mutations identify the ATP-binding region as the functional domain inhibited by bicyclomycin. Strains containing the S266C, S266A and L208R Rho mutations are very resistant to bicyclomycin in vivo. In a similar way, the mutant Rho proteins containing these mutations are very resistant to bicyclomycin in vitro. These data suggest that Ser266 and Leu208 might make direct contact with the antibiotic. These two residues are close to each other in the tertiary structure of a model of Rho based on the alpha and beta subunits of the F(1) ATPase, supporting the validity of the model. The strain containing the G337S Rho mutation also has high bicyclomycin resistance, and the proximity of L208, S266 and G337 in the quaternary structure of the Rho model has enabled a candidate bicyclomycin-binding pocket to be delineated. As a whole, the bicyclomycin sensitivities of the mutants are consistent with the locations of their respective mutations in the model of Rho based on the F(1) ATPase, therefore supporting the emerging consensus model of Rho structure.
Copyright 2000 Academic Press.
Similar articles
-
Phenotypic characterization of a comprehensive set of bicyclomycin-resistant mutants.Biochim Biophys Acta. 2001 Sep 21;1520(3):223-33. doi: 10.1016/s0167-4781(01)00271-8. Biochim Biophys Acta. 2001. PMID: 11566358
-
Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.Biochemistry. 1993 Apr 13;32(14):3564-70. doi: 10.1021/bi00065a007. Biochemistry. 1993. PMID: 8466900
-
Rho transcription factor: symmetry and binding of bicyclomycin.Biochemistry. 2000 Aug 8;39(31):9077-83. doi: 10.1021/bi000504+. Biochemistry. 2000. PMID: 10924100
-
The molecular basis for the mode of action of bicyclomycin.Curr Drug Targets Infect Disord. 2005 Sep;5(3):273-95. doi: 10.2174/1568005054880136. Curr Drug Targets Infect Disord. 2005. PMID: 16181146 Review.
-
Structural organization of transcription termination factor Rho.J Biol Chem. 1996 Jan 19;271(3):1251-4. doi: 10.1074/jbc.271.3.1251. J Biol Chem. 1996. PMID: 8576105 Review. No abstract available.
Cited by
-
Bacterial Transcription as a Target for Antibacterial Drug Development.Microbiol Mol Biol Rev. 2016 Jan 13;80(1):139-60. doi: 10.1128/MMBR.00055-15. Print 2016 Mar. Microbiol Mol Biol Rev. 2016. PMID: 26764017 Free PMC article. Review.
-
Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics.J Antimicrob Chemother. 2014 Dec;69(12):3227-35. doi: 10.1093/jac/dku285. Epub 2014 Jul 31. J Antimicrob Chemother. 2014. PMID: 25085655 Free PMC article.
-
Diversification of the Rho transcription termination factor in bacteria.Nucleic Acids Res. 2024 Aug 27;52(15):8979-8997. doi: 10.1093/nar/gkae582. Nucleic Acids Res. 2024. PMID: 38966992 Free PMC article.
-
Study of bicyclomycin biosynthesis in Streptomyces cinnamoneus by genetic and biochemical approaches.Sci Rep. 2019 Dec 27;9(1):20226. doi: 10.1038/s41598-019-56747-7. Sci Rep. 2019. PMID: 31882990 Free PMC article.
-
Mastering the control of the Rho transcription factor for biotechnological applications.Appl Microbiol Biotechnol. 2021 May;105(10):4053-4071. doi: 10.1007/s00253-021-11326-7. Epub 2021 May 8. Appl Microbiol Biotechnol. 2021. PMID: 33963893 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials